Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Humacyte, Inc. (HUMA)
USD0.69
-0.02 (-2.59%)
US NASDAQ Healthcare Biotechnology
Address
2525 East North Carolina Highway 54 27713
Durham, NC, US
Durham, NC, US
CEO
Laura E. Niklason
Website
humacyte.com
IPO
2020-12-01
CIK 1818382 ISIN US44486Q1031
Also trades on
NASDAQ Global Select · AHAC (USD)
NASDAQ Global Select · AHACU (USD)
NASDAQ Global Select · HUMA (USD)
NASDAQ Global Select · HUMAW (USD)
Description
Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomical locations and therapeutic fields. The company employs its distinct scientific and proprietary technology platform to produce human acellular vessels (HAVs). These investigational HAVs are specifically crafted for universal compatibility, enabling easy implantation into any patient without inducing an immune rejection or an adverse foreign body response. Humacyte is currently building a pipeline of HAVs targeting the substantial market for vascular repair, reconstruction, and replacement. This includes applications such as treating vascular trauma, providing arteriovenous access for hemodialysis, addressing peripheral arterial disease, and facilitating coronary artery bypass grafting. Furthermore, the company is exploring the use of its HAVs for pediatric heart surgeries and for cellular therapeutic delivery, including the transplantation of pancreatic islet cells to manage Type 1 diabetes. Founded in 2004, Humacyte maintains its headquarters in Durham, North Carolina.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Alpha Healthcare Acquisition Corp. | AHACU | 2021-03-22 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.69
-0.02 (-2.59%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
10M
Beta
2.46
Float Shares
128.89M
Free Float %
82.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -9.00% | -14.95% | +35.80% | -9.90% | -23.53% | -5.26% | -47.40% | -77.16% | -90.78% | -90.59% | -90.59% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (11 ratings, all time)
Buy
Price Targets & DCF
Current price
0.69
Low
3.00
+335.5%
Consensus
3.00
+335.5%
Median
3.00
+335.5%
High
3.00
+335.5%
Ratings Trend (MoM)
86% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 4 | -1 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 3 |
4.17
+505.3%
|
| All Time | 7 |
5.36
+678.1%
|
Quality scores
Altman Z-Score
-10.51
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%— Q1'26: -4.3% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+79.4% ★ Q1'26: -132.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-6,654.6% Q1'26: -5,106.9% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-5,271.7% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-615.4% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+33.5% Q1'26: +50.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.65× Q1'26: -0.57× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.26M
est: 1.22M (+3.2%)
|
1.57M
est: 1.77M (-11.5%)
|
—
est: 50.0K (-100.0%)
|
—
est: 214.3K (-100.0%)
|
2.04M
est: 2.73M (-25.4%)
|
11.18M
10.73M – 11.61M
+309.1% YoY
|
61.54M
45.78M – 77.31M
+450.7% YoY
|
263.49M
154.06M – 506.38M
+328.1% YoY
|
440.31M
257.44M – 846.21M
+67.1% YoY
|
780.47M
456.33M – 1.50B
+77.3% YoY
|
| EBITDA |
-72.97M
est: -244.9K (-29,698.7%)
|
-76.37M
est: -353.6K (-21,499.4%)
|
-96.46M
est: -10.0K (-964,576.5%)
|
-132.23M
est: -42.9K (-308,447.0%)
|
-100.09M
est: -546.3K (-18,222.0%)
|
-2.24M
-2.32M – -2.15M
-309.1% YoY
|
-12.31M
-15.46M – -9.16M
-450.7% YoY
|
-52.70M
-101.28M – -30.81M
-328.1% YoY
|
-88.06M
-169.24M – -51.49M
-67.1% YoY
|
-156.09M
-299.99M – -91.27M
-77.3% YoY
|
| EBIT |
-81.21M
est: -244.9K (-33,064.3%)
|
-84.58M
est: -353.6K (-23,821.4%)
|
-104.18M
est: -10.0K (-1,041,774.2%)
|
-139.42M
est: -42.9K (-325,223.8%)
|
-107.44M
est: -546.3K (-19,566.6%)
|
-2.24M
-2.32M – -2.15M
-309.1% YoY
|
-12.31M
-15.46M – -9.16M
-450.7% YoY
|
-52.70M
-101.28M – -30.81M
-328.1% YoY
|
-88.06M
-169.24M – -51.49M
-67.1% YoY
|
-156.09M
-299.99M – -91.27M
-77.3% YoY
|
| Net Income |
-26.48M
est: -183.33M (+85.6%)
|
-11.97M
est: -88.68M (+86.5%)
|
-110.78M
est: -139.66M (+20.7%)
|
-148.70M
est: -200.69M (+25.9%)
|
-40.83M
est: -45.42M (+10.1%)
|
-70.29M
-80.83M – -59.74M
-54.7% YoY
|
-38.28M
-46.16M – -30.40M
+45.5% YoY
|
94.07M
-16.36M – 240.80M
+345.8% YoY
|
199.81M
91.93M – 439.26M
+112.4% YoY
|
394.87M
181.68M – 868.09M
+97.6% YoY
|
| SGA |
21.13M
est: 10.14M (+108.4%)
|
22.88M
est: 14.64M (+56.3%)
|
20.39M
est: 414.1K (+4,824.1%)
|
25.80M
est: 2.08M (+1,137.4%)
|
31.17M
est: 26.58M (+17.3%)
|
108.73M
104.42M – 112.92M
+309.1% YoY
|
598.77M
445.39M – 752.15M
+450.7% YoY
|
2.56B
1.50B – 4.93B
+328.1% YoY
|
4.28B
2.50B – 8.23B
+67.1% YoY
|
7.59B
4.44B – 14.59B
+77.3% YoY
|
| EPS |
-0.66
est: -1.55 (+57.3%)
|
-0.12
est: -0.41 (+70.7%)
|
-1.07
est: -1.05 (-1.8%)
|
-1.26
est: -1.35 (+6.6%)
|
-0.26
est: -0.29 (+11.3%)
|
-0.43
-0.51 – -0.38
-47.8% YoY
|
-0.23
-0.29 – -0.19
+47.4% YoY
|
0.36
-0.10 – 1.52
+259.8% YoY
|
1.26
0.58 – 2.78
+247.1% YoY
|
2.50
1.15 – 5.49
+97.6% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-28 | D. Boral Capital | Buy | Buy | Maintain |
| 2026-04-24 | D. Boral Capital | Buy | Buy | Maintain |
| 2026-04-21 | D. Boral Capital | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-912.68M
OE per share TTM
-6.09
Owner's Yield
-634.13%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
3,002.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
73
Total invested
13.88M
Insider transactions (90d)
0
Beneficial owners (>5%)
17
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Brady W. Dougan | 22.34M | 21.30% | — | 22.34M | — | 10.00 | IN | United States of America | 2022-09-19 | ↗ |
| 2 | Laura E. Niklason | 22.34M | 21.30% | — | 22.34M | — | 10.00 | IN | United States of America | 2022-09-19 | ↗ |
| 3 | Ayabudge LLC | 18.93M | 18.40% | — | 18.93M | — | 10.00 | OO | Delaware, United States of America | 2022-09-19 | ↗ |
| 4 | Fresenius Medical Care AG & Co. KGaA | 18.31M | 17.80% | — | 18.31M | — | 11.00 | PN | — | 2021-09-02 | ↗ |
| 5 | Fresenius Medical Care Holdings, Inc. | 18.31M | 17.80% | — | 18.31M | — | 11.00 | CO | — | 2021-09-02 | ↗ |
| 6 | Gavril Abramovich Yushvaev | 8.94M | 8.70% | — | 8.94M | — | 8.94M | IN | Russian and Israeli | 2021-09-08 | ↗ |
| 7 | PTC Trustees GY Limited as Trustee of The GYF Trust | 8.94M | 8.70% | — | 8.94M | — | 8.94M | OO | Russian and Israeli | 2021-09-08 | ↗ |
| 8 | (1) BlackRock, Inc. | 7.54M | 6.30% | 7.44M | — | 7.54M | — | HC | Delaware | 2024-11-08 | ↗ |
| 9 | AHAC Sponsor LLC | 3.08M | 23.30% | — | 3.08M | — | 3.08M | OO | Delaware | 2020-09-25 | ↗ |
| 10 | Rajiv Shukla | 3.08M | 23.30% | — | 3.08M | — | 3.08M | IN | India | 2020-09-25 | ↗ |
| 11 | I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | 844.7K | 8.16% | — | 844.7K | — | 844.7K | — | Delaware | 2021-03-01 | ↗ |
| 12 | CCZG LLC | — | 0.00% | — | — | — | — | HC | OR PLACE OF ORGANIZATION | 2022-02-09 | ↗ |
| 13 | Glazer Capital, LLC | — | 0.00% | — | — | — | — | IA, OO | State of Delaware | 2022-02-14 | ↗ |
| 14 | Parian Global Management LP | — | 0.00% | — | — | — | — | IA | OR PLACE OF ORGANIZATION | 2022-02-09 | ↗ |
| 15 | Parian Global Master Fund LP | — | 0.00% | — | — | — | — | PN | OR PLACE OF ORGANIZATION | 2022-02-09 | ↗ |
| 16 | Paul J. Glazer | — | 0.00% | — | — | — | — | IN | United States | 2022-02-14 | ↗ |
| 17 | Zachary C. Miller | — | 0.00% | — | — | — | — | IN | OR PLACE OF ORGANIZATION | 2022-02-09 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
73
-78 vs prev Q
New positions
12
Closed positions
84
Increased
37
Reduced
12
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 11.35M +1.4M (+14.6%) | 10.90M -6.3M (-36.8%) | 7.17% +0.796 pp | 0.00% 0.000 pp | USD4.29 -77.6% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 8.42M +896.9K (+11.9%) | 8.09M -5.0M (-38.2%) | 5.32% +0.479 pp | 0.00% 0.000 pp | USD4.27 -77.5% | 18 qtrs — |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 3.72M +624.2K (+20.2%) | 3.57M -1.8M (-33.7%) | 2.35% +0.358 pp | 0.00% 0.000 pp | USD3.49 -72.5% | 18 qtrs — |
| 4 | UBS GROUP AG | 2.98M +976.3K (+48.8%) | 2.86M -621.6K (-17.8%) | 1.88% +0.593 pp | 0.00% 0.000 pp | USD2.55 -62.4% | 18 qtrs — |
| 5 | STATE STREET CORP | 2.84M +429.2K (+17.8%) | 2.73M -1.5M (-35.0%) | 1.79% +0.243 pp | 0.00% 0.000 pp | USD4.31 -77.7% | 17 qtrs — |
| 6 | MILLENNIUM MANAGEMENT LLC | 2.63M +1.5M (+129.5%) | 2.53M +532.5K (+26.7%) | 1.66% +0.925 pp | 0.00% +0.000 pp | USD1.88 -48.9% | 16 qtrs — |
| 7 | MORGAN STANLEY | 2.51M +408.7K (+19.5%) | 2.41M -1.2M (-34.0%) | 1.58% +0.234 pp | 0.00% 0.000 pp | USD2.53 -62.1% | 18 qtrs — |
| 8 | WOODLINE PARTNERS LP | 2.00M +— (+0.0%) | 1.92M -1.6M (-44.8%) | 1.26% -0.023 pp | 0.01% -0.009 pp | USD4.20 -77.1% | 6 qtrs — |
| 9 | TWO SIGMA INVESTMENTS, LP | 1.49M +124.9K (+9.1%) | 1.43M -945.3K (-39.8%) | 0.94% +0.063 pp | 0.00% -0.002 pp | USD3.12 -69.2% | 10 qtrs — |
| 10 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.24M +227.6K (+22.5%) | 1.19M -570.2K (-32.4%) | 0.78% +0.132 pp | 0.00% 0.000 pp | USD3.80 -74.7% | 17 qtrs — |
| 11 | NORTHERN TRUST CORP | 1.15M +115.5K (+11.2%) | 1.10M -693.1K (-38.6%) | 0.72% +0.061 pp | 0.00% 0.000 pp | USD3.60 -73.3% | 17 qtrs — |
| 12 | BNP PARIBAS ARBITRAGE, SNC | 1.10M +1.0M (+1,100.0%) | 1.06M +897.7K (+562.4%) | 0.70% +0.636 pp | 0.00% +0.000 pp | USD1.08 -11.1% | 5 qtrs — |
| 13 | LPL FINANCIAL LLC | 837.7K +46.9K (+5.9%) | 804.6K -571.3K (-41.5%) | 0.53% +0.020 pp | 0.00% 0.000 pp | USD2.89 -66.8% | 18 qtrs — |
| 14 | BARCLAYS PLC | 729.5K +492.7K (+208.1%) | 700.7K -587.2K (-45.6%) | 0.46% +0.309 pp | 0.00% 0.000 pp | USD1.71 -43.9% | 16 qtrs — |
| 15 | XTX TOPCO LTD | 650.9K +457.2K (+236.1%) | 625.1K +288.2K (+85.6%) | 0.41% +0.287 pp | 0.02% -0.001 pp | USD1.44 -33.3% | 7 qtrs — |
| 16 | PRIVATE ADVISOR GROUP, LLC | 561.6K -467.5K (-45.4%) | 539.4K -1.3M (-69.9%) | 0.35% -0.307 pp | 0.00% -0.006 pp | USD3.16 -69.6% | 15 qtrs — |
| 17 | JANE STREET GROUP, LLC | 518.9K +423.2K (+442.2%) | 498.4K +331.9K (+199.3%) | 0.33% +0.266 pp | 0.00% +0.000 pp | USD1.14 -15.8% | 12 qtrs — |
| 18 | LION POINT CAPITAL, LP | 500.0K +416.5K (+498.8%) | 480.3K +335.0K (+230.5%) | 0.32% +0.262 pp | 2.49% +1.660 pp | USD1.09 -11.9% | 4 qtrs — |
| 19 | MARSHALL WACE, LLP | 488.4K -330.6K (-40.4%) | 468.8K -956.1K (-67.1%) | 0.31% -0.218 pp | 0.00% -0.001 pp | USD2.15 -55.3% | 10 qtrs — |
| 20 | SQUAREPOINT OPS LLC | 458.2K +458.2K (+100.0%) | 440.1K +440.1K (+100.0%) | 0.29% +0.289 pp | 0.00% +0.001 pp | USD0.96 +0.0% | 8 qtrs — |
| 21 | BANK OF AMERICA CORP /DE/ | 452.2K -28.8K (-6.0%) | 434.1K -402.8K (-48.1%) | 0.29% -0.024 pp | 0.00% +0.000 pp | USD3.90 -75.4% | 18 qtrs — |
| 22 | GOLDMAN SACHS GROUP INC | 427.2K -62.0K (-12.7%) | 410.4K -440.9K (-51.8%) | 0.27% -0.045 pp | 0.00% 0.000 pp | USD4.62 -79.2% | 17 qtrs — |
| 23 | BANK OF NEW YORK MELLON CORP | 343.8K +21.4K (+6.6%) | 330.2K -230.7K (-41.1%) | 0.22% +0.010 pp | 0.00% 0.000 pp | USD2.93 -67.2% | 16 qtrs — |
| 24 | LJI WEALTH MANAGEMENT, LLC | 308.5K -7.5K (-2.4%) | 296.3K -253.5K (-46.1%) | 0.19% -0.008 pp | 0.05% -0.051 pp | USD3.74 -74.3% | 5 qtrs — |
| 25 | GROUP ONE TRADING, L.P. | 264.6K +125.1K (+89.7%) | 254.1K +11.5K (+4.7%) | 0.17% +0.077 pp | 0.00% +0.000 pp | USD1.44 -33.3% | 3 qtrs — |
| 26 | VIRTU FINANCIAL LLC | 262.7K +262.7K (+100.0%) | 252.0K +252.0K (+100.0%) | 0.17% +0.166 pp | 0.01% +0.010 pp | USD0.96 +0.0% | 3 qtrs — |
| 27 | NUVEEN, LLC | 261.5K +— (+0.0%) | 251.2K -203.8K (-44.8%) | 0.17% -0.003 pp | 0.00% 0.000 pp | USD1.71 -43.9% | 4 qtrs — |
| 28 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 260.2K -129.3K (-33.2%) | 249.8K -427.9K (-63.1%) | 0.16% -0.086 pp | 0.00% +0.000 pp | USD4.70 -79.6% | 10 qtrs — |
| 29 | CITADEL ADVISORS LLC | 250.7K +73.8K (+41.7%) | 240.8K -67.0K (-21.8%) | 0.16% +0.045 pp | 0.00% +0.000 pp | USD1.95 -50.8% | 18 qtrs — |
| 30 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 210.0K +35.0K (+20.0%) | 201.7K -102.8K (-33.8%) | 0.13% +0.020 pp | 0.00% -0.002 pp | USD1.90 -49.5% | 3 qtrs — |
| 31 | UNITED ASSET STRATEGIES, INC. | 209.6K +25.0K (+13.5%) | 201.3K -119.9K (-37.3%) | 0.13% +0.014 pp | 0.02% -0.010 pp | USD2.96 -67.6% | 18 qtrs — |
| 32 | QUADRATURE CAPITAL LTD | 209.0K +209.0K (+100.0%) | 200.7K +200.7K (+100.0%) | 0.13% +0.132 pp | 0.00% +0.002 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 33 | RHUMBLINE ADVISERS | 178.2K +2.7K (+1.5%) | 171.2K -134.1K (-43.9%) | 0.11% 0.000 pp | 0.00% 0.000 pp | USD3.26 -70.6% | 15 qtrs — |
| 34 | WELLS FARGO & COMPANY/MN | 174.5K +76.4K (+78.0%) | 167.6K -3.0K (-1.7%) | 0.11% +0.047 pp | 0.00% +0.000 pp | USD2.17 -55.8% | 18 qtrs — |
| 35 | ARISTIDES CAPITAL LLC | 162.9K +162.9K (+100.0%) | 156.5K +156.5K (+100.0%) | 0.10% +0.103 pp | 0.03% +0.028 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 36 | SHAY CAPITAL LLC | 160.9K +160.9K (+100.0%) | 154.5K +154.5K (+100.0%) | 0.10% +0.102 pp | 0.02% +0.016 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 37 | WEALTH EFFECTS LLC | 153.1K -55.0K (-26.4%) | 147.0K -214.9K (-59.4%) | 0.10% -0.037 pp | 0.05% -0.070 pp | USD3.38 -71.6% | 6 qtrs — |
| 38 | ALLIANCEBERNSTEIN L.P. | 145.6K +— (+0.0%) | 139.8K -113.5K (-44.8%) | 0.09% -0.002 pp | 0.00% +0.000 pp | USD2.98 -67.8% | 13 qtrs — |
| 39 | TWO SIGMA ADVISERS, LP | 144.1K -99.0K (-40.7%) | 138.4K -284.6K (-67.3%) | 0.09% -0.065 pp | 0.00% -0.001 pp | USD2.49 -61.4% | 9 qtrs — |
| 40 | VOLEON CAPITAL MANAGEMENT LP | 135.8K +135.8K (+100.0%) | 130.5K +130.5K (+100.0%) | 0.09% +0.086 pp | 0.00% +0.003 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 41 | DEUTSCHE BANK AG\ | 108.8K +7.7K (+7.6%) | 104.4K -71.5K (-40.6%) | 0.07% +0.004 pp | 0.00% +0.000 pp | USD3.57 -73.1% | 15 qtrs — |
| 42 | ENDOWMENT WEALTH MANAGEMENT, INC. | 105.9K -3.5K (-3.2%) | 96.9K -93.6K (-49.1%) | 0.07% -0.004 pp | 0.04% -0.042 pp | USD6.84 -86.0% | 17 qtrs — |
| 43 | ENGINEERS GATE MANAGER LP | 85.0K +85.0K (+100.0%) | 81.6K +81.6K (+100.0%) | 0.05% +0.054 pp | 0.00% +0.001 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 44 | PRICE T ROWE ASSOCIATES INC /MD/ | 76.0K +13.2K (+21.0%) | 73.0K -37.0K (-33.6%) | 0.05% +0.008 pp | 0.00% +0.000 pp | USD2.83 -66.1% | 12 qtrs — |
| 45 | JPMORGAN CHASE & CO | 75.8K +11.6K (+18.1%) | 72.8K -38.9K (-34.8%) | 0.05% +0.007 pp | 0.00% +0.000 pp | USD2.92 -67.1% | 17 qtrs — |
| 46 | KOVACK ADVISORS, INC. | 72.6K +72.6K (+100.0%) | 69.7K +69.7K (+100.0%) | 0.05% +0.046 pp | 0.00% +0.003 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 47 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 72.0K +13.2K (+22.4%) | 69.2K -33.2K (-32.5%) | 0.05% +0.008 pp | 0.00% 0.000 pp | USD3.96 -75.8% | 7 qtrs — |
| 48 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 70.4K +62.9K (+841.0%) | 67.6K +54.6K (+419.5%) | 0.04% +0.040 pp | 0.02% +0.007 pp | USD1.10 -12.7% | 5 qtrs — |
| 49 | TUDOR INVESTMENT CORP ET AL | 70.0K +70.0K (+100.0%) | 67.2K +67.2K (+100.0%) | 0.04% +0.044 pp | 0.00% +0.000 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 50 | LASALLE ST. INVESTMENT ADVISORS, LLC | 68.9K +1.6K (+2.4%) | 66.0K -51.0K (-43.6%) | 0.04% +0.000 pp | 0.01% -0.010 pp | USD1.80 -46.7% | 4 qtrs — |
| 51 | CETERA INVESTMENT ADVISERS | 68.1K -2.4K (-3.4%) | 65.4K -57.3K (-46.7%) | 0.04% -0.002 pp | 0.00% 0.000 pp | USD2.81 -65.8% | 8 qtrs — |
| 52 | ADVISOR GROUP HOLDINGS, INC. | 66.0K -7.9K (-10.7%) | 63.4K -58.3K (-47.9%) | 0.04% -0.006 pp | 0.00% 0.000 pp | USD6.06 -84.2% | 18 qtrs — |
| 53 | INTECH INVESTMENT MANAGEMENT LLC | 60.7K -60.0 (-0.1%) | 58.3K -47.5K (-44.9%) | 0.04% -0.001 pp | 0.00% 0.000 pp | USD4.12 -76.7% | 6 qtrs — |
| 54 | CONCURRENT INVESTMENT ADVISORS, LLC | 60.0K +364.0 (+0.6%) | 57.6K -46.1K (-44.5%) | 0.04% -0.001 pp | 0.00% -0.001 pp | USD3.65 -73.7% | 6 qtrs — |
| 55 | BROKERS INTERNATIONAL FINANCIAL SERVICES, LLC. | 57.3K +— (+0.0%) | 55.0K -44.7K (-44.8%) | 0.04% -0.001 pp | 0.00% -0.003 pp | USD1.71 -43.9% | 4 qtrs — |
| 56 | CREATIVE PLANNING | 55.9K +11.9K (+27.0%) | 53.7K -22.9K (-29.9%) | 0.04% +0.007 pp | 0.00% +0.000 pp | USD1.57 -38.9% | 2 qtrs — |
| 57 | TRILOGY CAPITAL INC. | 54.8K -75.0K (-57.8%) | 52.6K -173.2K (-76.7%) | 0.03% -0.049 pp | 0.00% -0.008 pp | USD3.35 -71.3% | 5 qtrs — |
| 58 | RAYMOND JAMES FINANCIAL INC | 51.3K -20.8K (-28.8%) | 49.3K -76.2K (-60.7%) | 0.03% -0.014 pp | 0.00% +0.000 pp | USD2.25 -57.3% | 5 qtrs — |
| 59 | FISHER ASSET MANAGEMENT, LLC | 49.4K +49.4K (+100.0%) | 47.4K +47.4K (+100.0%) | 0.03% +0.031 pp | 0.00% +0.000 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 60 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 48.8K +6.3K (+14.7%) | 46.9K -27.2K (-36.7%) | 0.03% +0.004 pp | 0.00% +0.000 pp | USD2.94 -67.3% | 13 qtrs — |
| 61 | CLARUS WEALTH ADVISORS | 40.0K +— (+0.0%) | 44.4K -39.6K (-47.1%) | 0.03% -0.001 pp | 0.02% -0.019 pp | USD5.04 -81.0% | 5 qtrs — |
| 62 | LETKO, BROSSEAU & ASSOCIATES INC | 46.0K +— (+0.0%) | 44.1K -35.8K (-44.8%) | 0.03% -0.001 pp | 0.00% -0.001 pp | USD1.88 -48.9% | 4 qtrs — |
| 63 | JAIN GLOBAL LLC | 39.4K +39.4K (+100.0%) | 37.8K +37.8K (+100.0%) | 0.02% +0.025 pp | 0.00% +0.000 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 64 | INVESCO LTD. | 38.8K +5.1K (+15.1%) | 37.3K -21.4K (-36.5%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD3.10 -69.0% | 15 qtrs — |
| 65 | PROSHARE ADVISORS LLC | 36.6K +9.6K (+35.3%) | 35.2K -11.9K (-25.3%) | 0.02% +0.006 pp | 0.00% +0.000 pp | USD3.54 -72.9% | 17 qtrs — |
| 66 | BEACON POINTE ADVISORS, LLC | 36.0K +— (+0.0%) | 34.6K -28.1K (-44.8%) | 0.02% 0.000 pp | 0.00% 0.000 pp | USD3.79 -74.7% | 7 qtrs — |
| 67 | SG AMERICAS SECURITIES, LLC | 34.1K +11.4K (+50.3%) | 33.0K -6.0K (-15.4%) | 0.02% +0.007 pp | 0.00% 0.000 pp | USD3.62 -73.5% | 6 qtrs — |
| 68 | AQR CAPITAL MANAGEMENT LLC | 33.8K -224.2K (-86.9%) | 32.5K -416.5K (-92.8%) | 0.02% -0.145 pp | 0.00% 0.000 pp | USD2.16 -55.6% | 9 qtrs — |
| 69 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 30.8K +— (+0.0%) | 29.6K -24.0K (-44.8%) | 0.02% 0.000 pp | 0.00% 0.000 pp | USD3.79 -74.7% | 5 qtrs — |
| 70 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 30.5K +2.8K (+9.9%) | 29.3K -19.0K (-39.3%) | 0.02% +0.001 pp | 0.00% -0.002 pp | USD3.50 -72.6% | 14 qtrs — |
| 71 | VOYA INVESTMENT MANAGEMENT LLC | 26.8K +5.0K (+22.8%) | 25.7K -12.2K (-32.2%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD2.58 -62.8% | 13 qtrs — |
| 72 | R SQUARED LTD | 26.2K +26.2K (+100.0%) | 25.1K +25.1K (+100.0%) | 0.02% +0.017 pp | 0.01% +0.012 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 73 | ATOM INVESTORS LP | 25.9K +25.9K (+100.0%) | 24.8K +24.8K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.002 pp | USD0.96 +0.0% | 3 qtrs — |
| 74 | HAMILTON LANE ADVISORS LLC | 21.9K +— (+0.0%) | 21.0K -17.1K (-44.8%) | 0.01% 0.000 pp | 0.01% -0.010 pp | USD1.71 -43.9% | 14 qtrs — |
| 75 | TRUST CO OF KANSAS | 20.0K +4.0K (+25.0%) | 19.0K -9.0K (-32.1%) | 0.01% +0.002 pp | 0.01% -0.005 pp | USD1.58 -39.2% | 2 qtrs — |
| 76 | WAVERLY ADVISORS, LLC | 19.1K -248.0K (-92.9%) | 18.3K -446.4K (-96.1%) | 0.01% -0.160 pp | 0.00% -0.005 pp | USD5.00 -80.8% | 8 qtrs — |
| 77 | HIGHTOWER ADVISORS, LLC | 18.3K -500.0 (-2.7%) | 17.6K -15.1K (-46.3%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD3.68 -73.9% | 5 qtrs — |
| 78 | VICTORY CAPITAL MANAGEMENT INC | 18.2K +3.1K (+20.6%) | 17.5K -8.8K (-33.4%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD3.95 -75.7% | 9 qtrs — |
| 79 | MERIT FINANCIAL GROUP, LLC | 18.0K -9.7K (-34.9%) | 17.3K -30.8K (-64.1%) | 0.01% -0.006 pp | 0.00% 0.000 pp | USD1.88 -48.9% | 4 qtrs — |
| 80 | PFG INVESTMENTS, LLC | 17.8K +17.8K (+100.0%) | 17.1K +17.1K (+100.0%) | 0.01% +0.011 pp | 0.00% +0.001 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 81 | RATHER & KITTRELL, INC. | 17.4K +— (+0.0%) | 16.7K -13.5K (-44.8%) | 0.01% 0.000 pp | 0.00% -0.003 pp | USD5.05 -81.0% | 5 qtrs — |
| 82 | UNITING WEALTH PARTNERS, LLC | 16.6K +— (+0.0%) | 16.0K -12.9K (-44.8%) | 0.01% 0.000 pp | 0.00% -0.002 pp | USD5.01 -80.8% | 5 qtrs — |
| 83 | REGIONS FINANCIAL CORP | 16.4K +— (+0.0%) | 15.8K -12.8K (-44.8%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD5.29 -81.9% | 7 qtrs — |
| 84 | IMPRINT WEALTH LLC | 16.4K -2.5K (-13.5%) | 15.7K -17.2K (-52.2%) | 0.01% -0.002 pp | 0.07% -0.032 pp | USD1.74 -44.8% | 2 qtrs — |
| 85 | COMMONWEALTH EQUITY SERVICES, LLC | 16.0K -3.7K (-18.6%) | 15.4K -18.6K (-54.8%) | 0.01% -0.003 pp | 0.00% +0.000 pp | USD4.19 -77.1% | 8 qtrs — |
| 86 | COLUMBIA ADVISORY PARTNERS LLC | 15.7K +— (+0.0%) | 15.1K -12.2K (-44.8%) | 0.01% 0.000 pp | 0.01% -0.009 pp | USD1.71 -43.9% | 4 qtrs — |
| 87 | LEGAL & GENERAL GROUP PLC | 15.6K +3.6K (+30.0%) | 15.0K -5.9K (-28.2%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD4.02 -76.1% | 17 qtrs — |
| 88 | NEW YORK STATE COMMON RETIREMENT FUND | 15.2K +— (+0.0%) | 14.6K -11.9K (-44.8%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD4.49 -78.6% | 15 qtrs — |
| 89 | CFS INVESTMENT ADVISORY SERVICES, LLC | 15.0K +15.0K (+100.0%) | 14.4K +14.4K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.001 pp | USD0.96 +0.0% | 1 qtrs NEW |
| 90 | EQUITABLE HOLDINGS, INC. | 15.0K -1.7K (-10.2%) | 14.4K -14.7K (-50.4%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD1.74 -44.8% | 2 qtrs — |
| 91 | VALEO FINANCIAL ADVISORS, LLC | 14.9K +— (+0.0%) | 14.3K -11.6K (-44.8%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD2.09 -54.1% | 3 qtrs — |
| 92 | INDEPENDENT ADVISOR ALLIANCE | 14.5K -21.7K (-60.0%) | 13.9K -49.1K (-77.9%) | 0.01% -0.014 pp | 0.00% -0.001 pp | USD1.86 -48.4% | 4 qtrs — |
| 93 | LAZARI CAPITAL MANAGEMENT, INC. | 13.1K +100.0 (+0.8%) | 12.6K -10.1K (-44.4%) | 0.01% 0.000 pp | 0.00% -0.003 pp | USD2.08 -53.8% | 3 qtrs — |
| 94 | BROWN ADVISORY INC | 13.1K +— (+0.0%) | 12.6K -10.2K (-44.8%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD11.61 -91.7% | 18 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 25 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Biotechnology ETF IBB | 0.01% | 1.02M | 0.44% |
| 2 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.01% | 48.8K | 0.40% |
| 3 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.01% | 7.9K | 0.19% |
| 4 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.01% | 7.7K | 0.35% |
| 5 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.01% | 115.2K | 0.35% |
| 6 | Vanguard Russell 2000 Value ETF VTWV | 0.01% | 130.0K | 0.06% |
| 7 | Vanguard Russell 2000 ETF VTWO | 0.01% | 1.06M | 0.06% |
| 8 | Invesco RAFI US 1500 Small-Mid ETF PRFZ | 0.01% | 168.6K | 0.34% |
| 9 | ProShares Ultra Nasdaq Biotechnology BIB | 0.01% | 5.2K | 1.19% |
| 10 | Vanguard Health Care ETF VHT | 0.00% | 736.8K | 0.09% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
1.24M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+1,244,400
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-16 | Sander Dale A. | Officer | A-Award | A | Common Stock | 311,100 | 0.00 | — | 313,100 | D | ↗ |
| 2025-11-16 | Parikh Shamik J | Officer | A-Award | A | Common Stock | 311,100 | 0.00 | — | 318,600 | D | ↗ |
| 2025-11-16 | Niklason Laura E | Director / Officer | A-Award | A | Stock Options (right to buy) | 311,100 | 1.23 | 382.7K | 311,100 | D | ↗ |
| 2025-11-16 | Dougan Brady W | Director | A-Award | A | Stock Options (right to buy) | 311,100 | 1.23 | 382.7K | 311,100 | I | ↗ |
| 2025-08-20 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 591,685 | 1.58 | 934.9K | 0 | I | ↗ |
| 2025-08-20 | Dougan Brady W | Director | S-Sale | D | Common Stock | 591,685 | 1.58 | 934.9K | 0 | I | ↗ |
| 2025-08-19 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 1,100,000 | 1.63 | 1.79M | 591,685 | I | ↗ |
| 2025-08-19 | Dougan Brady W | Director | S-Sale | D | Common Stock | 1,100,000 | 1.63 | 1.79M | 591,685 | I | ↗ |
| 2025-08-18 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 549,360 | 1.83 | 1.01M | 1,691,685 | I | ↗ |
| 2025-08-18 | Dougan Brady W | Director | S-Sale | D | Common Stock | 549,360 | 1.83 | 1.01M | 1,691,685 | I | ↗ |
| 2025-06-12 | Windham-Bannister Susan Richards | Director | A-Award | A | Stock Options (right to buy) | 80,000 | 2.41 | 192.8K | 80,000 | D | ↗ |
| 2025-06-12 | Wallace Max N. | Director | A-Award | A | Stock Options (right to buy) | 80,000 | 2.41 | 192.8K | 80,000 | D | ↗ |
| 2025-06-12 | Seimetz Diane | Director | A-Award | A | Stock Options (right to buy) | 80,000 | 2.41 | 192.8K | 80,000 | D | ↗ |
| 2025-06-12 | Sebelius Kathleen | Director | A-Award | A | Stock Options (right to buy) | 80,000 | 2.41 | 192.8K | 80,000 | D | ↗ |
| 2025-06-12 | Pope Todd | Director | A-Award | A | Stock Options (right to buy) | 80,000 | 2.41 | 192.8K | 80,000 | D | ↗ |
| 2025-06-12 | Niklason Laura E | Director / Officer | A-Award | A | Stock Options (right to buy) | 0 | 2.41 | — | 0 | I | ↗ |
| 2025-06-12 | Jones Keith Anthony | Director | A-Award | A | Stock Options (right to buy) | 80,000 | 2.41 | 192.8K | 80,000 | D | ↗ |
| 2025-06-12 | Green Charles Bruce | Director | A-Award | A | Stock Options (right to buy) | 80,000 | 2.41 | 192.8K | 80,000 | D | ↗ |
| 2025-06-12 | Dougan Brady W | Director | A-Award | A | Stock Options (right to buy) | 0 | 2.41 | — | 0 | D | ↗ |
| 2025-06-12 | Constantino Michael T. | Director | A-Award | A | Stock Options (right to buy) | 80,000 | 2.41 | 192.8K | 80,000 | D | ↗ |
| 2025-06-12 | Brown Emery N. | Director | A-Award | A | Stock Options (right to buy) | 80,000 | 2.41 | 192.8K | 80,000 | D | ↗ |
| 2025-06-12 | Bamforth John Philip | Director | A-Award | A | Stock Options (right to buy) | 80,000 | 2.41 | 192.8K | 80,000 | D | ↗ |
| 2025-04-14 | Scheessele William John | Officer | P-Purchase | A | Common Stock | 6,493 | 1.54 | 10.0K | 22,018 | D | ↗ |
| 2025-04-10 | Sander Dale A. | Officer | P-Purchase | A | Common Stock | 20,000 | 1.53 | 30.6K | 40,600 | I | ↗ |
| 2025-04-10 | Parikh Shamik J | Officer | P-Purchase | A | Common Stock | 7,500 | 1.55 | 11.6K | 7,500 | D | ↗ |
| 2025-04-08 | Sebelius Kathleen | Director | P-Purchase | A | Common Stock | 50,000 | 1.32 | 66.0K | 91,207 | D | ↗ |
| 2025-04-08 | Green Charles Bruce | Director | P-Purchase | A | Common Stock | 6,000 | 1.29 | 7.7K | 8,400 | D | ↗ |
| 2025-04-07 | Constantino Michael T. | Director | P-Purchase | A | Common Stock | 16,000 | 1.26 | 20.2K | 32,950 | D | ↗ |
| 2025-01-21 | Scheessele William John | Officer | A-Award | A | Stock Options (right to buy) | 283,101 | 4.56 | 1.29M | 283,101 | D | ↗ |
| 2025-01-21 | Sander Dale A. | Officer | A-Award | A | Stock Options (right to buy) | 283,101 | 4.56 | 1.29M | 283,101 | D | ↗ |
| 2025-01-21 | Prichard Heather Ledbetter | Officer | A-Award | A | Stock Options (right to buy) | 283,101 | 4.56 | 1.29M | 283,101 | D | ↗ |
| 2025-01-21 | Parikh Shamik J | Officer | A-Award | A | Stock Options (right to buy) | 283,101 | 4.56 | 1.29M | 283,101 | D | ↗ |
| 2025-01-21 | Niklason Laura E | Director / Officer | A-Award | A | Stock Options (right to buy) | 1,130,311 | 4.56 | 5.15M | 1,130,311 | D | ↗ |
| 2025-01-21 | Dougan Brady W | Director | A-Award | A | Stock Options (right to buy) | 1,130,311 | 4.56 | 5.15M | 1,130,311 | I | ↗ |
| 2025-01-21 | Cao Yang | Officer | A-Award | A | Stock Options (right to buy) | 283,101 | 4.56 | 1.29M | 283,101 | D | ↗ |
| 2024-12-19 | Sander Dale A. | Officer | A-Award | A | Stock Options (right to buy) | 525 | 10.28 | 5.4K | 2,625 | D | ↗ |
| 2024-12-19 | Prichard Heather Ledbetter | Officer | A-Award | A | Stock Options (right to buy) | 525 | 10.28 | 5.4K | 2,625 | D | ↗ |
| 2024-12-19 | Niklason Laura E | Director / Officer | A-Award | A | Stock Options (right to buy) | 525 | 10.28 | 5.4K | 2,625 | D | ↗ |
| 2024-12-19 | Dougan Brady W | Director | A-Award | A | Stock Options (right to buy) | 525 | 10.28 | 5.4K | 2,625 | I | ↗ |
| 2024-12-04 | Constantino Michael T. | Director | P-Purchase | A | Common Stock | 4,600 | 4.39 | 20.2K | 16,950 | D | ↗ |
| 2024-11-20 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 261,369 | 4.40 | 1.15M | 1,730,884 | I | ↗ |
| 2024-11-20 | Dougan Brady W | Director | S-Sale | D | Common Stock | 261,369 | 4.40 | 1.15M | 1,730,884 | I | ↗ |
| 2024-11-19 | Niklason Laura E | Director / Officer | P-Purchase | A | Common Stock | 1,797 | 4.44 | 8.0K | 243,851 | D | ↗ |
| 2024-11-19 | Dougan Brady W | Director | P-Purchase | A | Common Stock | 1,797 | 4.44 | 8.0K | 243,851 | I | ↗ |
| 2024-11-18 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 811,172 | 4.44 | 3.60M | 2,419,712 | I | ↗ |
| 2024-11-18 | Dougan Brady W | Director | S-Sale | D | Common Stock | 811,172 | 4.44 | 3.60M | 2,419,712 | I | ↗ |
| 2024-09-13 | Green Charles Bruce | Director | M-Exempt | D | Stock Options (right to buy) | 1,200 | 4.09 | 4.9K | 10,600 | — | ↗ |
| 2024-09-10 | Sebelius Kathleen | Director | M-Exempt | D | Stock Options (right to buy) | 4,521 | 4.34 | 19.6K | 3,979 | — | ↗ |
| 2024-09-10 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 288,674 | 5.23 | 1.51M | 3,230,884 | — | ↗ |
| 2024-09-10 | Dougan Brady W | Director | S-Sale | D | Common Stock | 288,674 | 5.23 | 1.51M | 3,230,884 | — | ↗ |
| 2024-09-09 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 157,704 | 5.42 | 854.8K | 3,519,558 | — | ↗ |
| 2024-09-09 | Dougan Brady W | Director | S-Sale | D | Common Stock | 157,704 | 5.42 | 854.8K | 3,519,558 | — | ↗ |
| 2024-08-29 | Niklason Laura E | Director / Officer | P-Purchase | A | Common Stock | 1,222 | 6.55 | 8.0K | 242,054 | — | ↗ |
| 2024-08-29 | Dougan Brady W | Director | P-Purchase | A | Common Stock | 1,222 | 6.55 | 8.0K | 242,054 | — | ↗ |
| 2024-08-28 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 277,090 | 6.47 | 1.79M | 4,029,374 | — | ↗ |
| 2024-08-28 | Dougan Brady W | Director | S-Sale | D | Common Stock | 277,090 | 6.47 | 1.79M | 4,029,374 | — | ↗ |
| 2024-08-27 | Sander Dale A. | Officer | M-Exempt | A | Common Stock | 39,389 | 2.56 | 100.8K | 41,389 | — | ↗ |
| 2024-08-27 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 252,676 | 6.71 | 1.70M | 4,306,464 | — | ↗ |
| 2024-08-27 | Dougan Brady W | Director | S-Sale | D | Common Stock | 252,676 | 6.71 | 1.70M | 4,306,464 | — | ↗ |
| 2024-08-15 | Constantino Michael T. | Director | P-Purchase | A | Common Stock | 3,100 | 6.29 | 19.5K | 12,350 | — | ↗ |
| 2024-06-14 | Sebelius Kathleen | Director | M-Exempt | D | Stock Options (right to buy) | 39,389 | 2.56 | 100.8K | 0 | — | ↗ |
| 2024-06-13 | Windham-Bannister Susan Richards | Director | A-Award | A | Stock Options (right to buy) | 50,000 | 7.20 | 360.0K | 50,000 | — | ↗ |
| 2024-06-13 | Wallace Max N. | Director | A-Award | A | Stock Options (right to buy) | 50,000 | 7.20 | 360.0K | 50,000 | — | ↗ |
| 2024-06-13 | Seimetz Diane | Director | A-Award | A | Stock Options (right to buy) | 50,000 | 7.20 | 360.0K | 50,000 | — | ↗ |
| 2024-06-13 | Sebelius Kathleen | Director | A-Award | A | Stock Options (right to buy) | 50,000 | 7.20 | 360.0K | 50,000 | — | ↗ |
| 2024-06-13 | Pope Todd | Director | A-Award | A | Stock Options (right to buy) | 50,000 | 7.20 | 360.0K | 50,000 | — | ↗ |
| 2024-06-13 | Niklason Laura E | Director / Officer | A-Award | A | Stock Options (right to buy) | 50,000 | 7.20 | 360.0K | 50,000 | — | ↗ |
| 2024-06-13 | Jones Keith Anthony | Director | A-Award | A | Stock Options (right to buy) | 75,000 | 7.20 | 540.0K | 75,000 | — | ↗ |
| 2024-06-13 | Green Charles Bruce | Director | A-Award | A | Stock Options (right to buy) | 50,000 | 7.20 | 360.0K | 50,000 | — | ↗ |
| 2024-06-13 | Dougan Brady W | Director | A-Award | A | Stock Options (right to buy) | 50,000 | 7.20 | 360.0K | 50,000 | — | ↗ |
| 2024-06-13 | Constantino Michael T. | Director | A-Award | A | Stock Options (right to buy) | 50,000 | 7.20 | 360.0K | 50,000 | — | ↗ |
| 2024-06-13 | Brown Emery N. | Director | A-Award | A | Stock Options (right to buy) | 50,000 | 7.20 | 360.0K | 50,000 | — | ↗ |
| 2024-06-13 | Bamforth John Philip | Director | A-Award | A | Stock Options (right to buy) | 75,000 | 7.20 | 540.0K | 75,000 | — | ↗ |
| 2024-06-12 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 271,518 | 7.30 | 1.98M | 4,559,140 | — | ↗ |
| 2024-06-12 | Dougan Brady W | Director | S-Sale | D | Common Stock | 271,518 | 7.30 | 1.98M | 4,559,140 | — | ↗ |
| 2024-06-11 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 76,630 | 7.02 | 537.9K | 4,830,658 | — | ↗ |
| 2024-06-11 | Jones Keith Anthony | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-11 | Dougan Brady W | Director | S-Sale | D | Common Stock | 76,630 | 7.02 | 537.9K | 4,830,658 | — | ↗ |
| 2024-06-11 | Bamforth John Philip | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-04 | Niklason Laura E | Director / Officer | P-Purchase | A | Common Stock | 2,362 | 6.35 | 15.0K | 240,832 | — | ↗ |
| 2024-06-04 | Dougan Brady W | Director | P-Purchase | A | Common Stock | 2,362 | 6.35 | 15.0K | 240,832 | — | ↗ |
| 2024-06-03 | Niklason Laura E | Director / Officer | P-Purchase | A | Common Stock | 2,050 | 7.37 | 15.1K | 238,470 | — | ↗ |
| 2024-06-03 | Dougan Brady W | Director | S-Sale | D | Common Stock | 190,214 | 7.42 | 1.41M | 5,191,140 | — | ↗ |
| 2024-05-31 | Prichard Heather Ledbetter | Officer | S-Sale | D | Common Stock | 2,625 | 9.41 | 24.7K | 0 | — | ↗ |
| 2024-05-31 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 716,573 | 7.78 | 5.57M | 5,474,567 | — | ↗ |
| 2024-05-31 | Dougan Brady W | Director | S-Sale | D | Common Stock | 93,213 | 8.93 | 832.4K | 5,381,354 | — | ↗ |
| 2024-05-30 | Prichard Heather Ledbetter | Officer | M-Exempt | D | Stock Options (right to buy) | 48,166 | 3.07 | 147.9K | 87,834 | — | ↗ |
| 2024-05-20 | Wallace Max N. | Director | P-Purchase | A | Common Stock | 3,990 | 6.29 | 25.1K | 3,990 | — | ↗ |
| 2024-05-20 | Green Charles Bruce | Director | M-Exempt | A | Common Stock | 600 | 4.09 | 2.5K | 1,200 | — | ↗ |
| 2024-05-17 | Green Charles Bruce | Director | M-Exempt | D | Stock Options (right to buy) | 600 | 4.09 | 2.5K | 12,400 | — | ↗ |
| 2024-05-15 | Binder Gordon M | Director | P-Purchase | A | Common Stock | 50,000 | 6.78 | 339.0K | 160,000 | — | ↗ |
| 2023-12-11 | Sander Dale A. | Officer | A-Award | A | Stock Options (right to buy) | 525 | 10.28 | 5.4K | 2,100 | — | ↗ |
| 2023-12-11 | Prichard Heather Ledbetter | Officer | A-Award | A | Stock Options (right to buy) | 525 | 10.28 | 5.4K | 2,100 | — | ↗ |
| 2023-12-11 | Niklason Laura E | Director / Officer | A-Award | A | Stock Options (right to buy) | 525 | 10.28 | 5.4K | 2,100 | — | ↗ |
| 2023-12-11 | Dougan Brady W | Director | A-Award | A | Stock Options (right to buy) | 525 | 10.28 | 5.4K | 2,100 | — | ↗ |
| 2023-12-08 | Scheessele William John | Officer | A-Award | A | Stock Options (right to buy) | 276,000 | 2.80 | 772.8K | 276,000 | — | ↗ |
| 2023-12-08 | Sander Dale A. | Officer | A-Award | A | Stock Options (right to buy) | 301,000 | 2.80 | 842.8K | 301,000 | — | ↗ |
| 2023-12-08 | Prichard Heather Ledbetter | Officer | A-Award | A | Stock Options (right to buy) | 290,000 | 2.80 | 812.0K | 290,000 | — | ↗ |
| 2023-12-08 | Parikh Shamik J | Officer | A-Award | A | Stock Options (right to buy) | 283,000 | 2.80 | 792.4K | 283,000 | — | ↗ |
| 2023-12-08 | Niklason Laura E | Director / Officer | A-Award | A | Stock Options (right to buy) | 803,000 | 2.80 | 2.25M | 803,000 | — | ↗ |
| 2023-12-08 | Dougan Brady W | Director | A-Award | A | Stock Options (right to buy) | 803,000 | 2.80 | 2.25M | 803,000 | — | ↗ |
| 2023-12-08 | Cao Yang | Officer | A-Award | A | Stock Options (right to buy) | 210,000 | 2.80 | 588.0K | 210,000 | — | ↗ |
| 2023-11-21 | Wallace Max N. | Director | M-Exempt | A | Common Stock | 6,564 | 1.19 | 7.8K | 56,550 | — | ↗ |
| 2023-10-10 | Niklason Laura E | Director / Officer | M-Exempt | A | Common Stock | 114,420 | 1.19 | 136.2K | 1,384,660 | — | ↗ |
| 2023-10-10 | Dougan Brady W | Director | M-Exempt | A | Common Stock | 114,420 | 1.19 | 136.2K | 1,384,660 | — | ↗ |
| 2023-09-14 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 2,000,000 | 2.78 | 5.56M | 6,191,140 | — | ↗ |
| 2023-09-14 | Dougan Brady W | Director | S-Sale | D | Common Stock | 2,000,000 | 2.78 | 5.56M | 6,191,140 | — | ↗ |
| 2023-08-21 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 602,443 | 3.39 | 2.04M | 8,191,140 | — | ↗ |
| 2023-08-21 | Dougan Brady W | Director | S-Sale | D | Common Stock | 602,443 | 3.39 | 2.04M | 8,191,140 | — | ↗ |
| 2023-08-21 | Ayabudge LLC | 10% Owner | S-Sale | D | Common Stock | 602,443 | 3.39 | 2.04M | 8,191,140 | — | ↗ |
| 2023-08-18 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 626,979 | 3.57 | 2.24M | 8,793,583 | — | ↗ |
| 2023-08-18 | Dougan Brady W | Director | S-Sale | D | Common Stock | 626,979 | 3.57 | 2.24M | 8,793,583 | — | ↗ |
| 2023-08-18 | Ayabudge LLC | 10% Owner | S-Sale | D | Common Stock | 626,979 | 3.57 | 2.24M | 8,793,583 | — | ↗ |
| 2023-08-17 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 570,174 | 3.68 | 2.10M | 9,420,562 | — | ↗ |
| 2023-08-17 | Dougan Brady W | Director | S-Sale | D | Common Stock | 570,174 | 3.68 | 2.10M | 9,420,562 | — | ↗ |
| 2023-08-17 | Ayabudge LLC | 10% Owner | S-Sale | D | Common Stock | 570,174 | 3.68 | 2.10M | 9,420,562 | — | ↗ |
| 2023-06-15 | Windham-Bannister Susan Richards | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 3.35 | 28.5K | 8,500 | — | ↗ |
| 2023-06-15 | Wallace Max N. | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 3.35 | 28.5K | 8,500 | — | ↗ |
| 2023-06-15 | Shukla Rajiv | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 3.35 | 28.5K | 8,500 | — | ↗ |
| 2023-06-15 | Seimetz Diane | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 3.35 | 28.5K | 8,500 | — | ↗ |
| 2023-06-15 | Sebelius Kathleen | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 3.35 | 28.5K | 8,500 | — | ↗ |
| 2023-06-15 | Pope Todd | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 3.35 | 28.5K | 8,500 | — | ↗ |
| 2023-06-15 | Niklason Laura E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 500,000 | 3.12 | 1.56M | 9,990,736 | — | ↗ |
| 2023-06-15 | Green Charles Bruce | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 3.35 | 28.5K | 8,500 | — | ↗ |
| 2023-06-15 | Dougan Brady W | Director / 10% Owner | S-Sale | D | Common Stock | 500,000 | 3.12 | 1.56M | 9,990,736 | — | ↗ |
| 2023-06-15 | Constantino Michael T. | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 3.35 | 28.5K | 8,500 | — | ↗ |
| 2023-06-15 | Brown Emery N. | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 3.35 | 28.5K | 8,500 | — | ↗ |
| 2023-06-15 | Binder Gordon M | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 3.35 | 28.5K | 8,500 | — | ↗ |
| 2023-06-15 | Ayabudge LLC | 10% Owner | S-Sale | D | Common Stock | 500,000 | 3.12 | 1.56M | 9,990,736 | — | ↗ |
| 2023-06-13 | Niklason Laura E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 4,875,000 | 2.60 | 12.68M | 10,490,736 | — | ↗ |
| 2023-06-13 | Dougan Brady W | Director / 10% Owner | S-Sale | D | Common Stock | 4,875,000 | 2.60 | 12.68M | 10,490,736 | — | ↗ |
| 2023-06-13 | Ayabudge LLC | 10% Owner | S-Sale | D | Common Stock | 4,875,000 | 2.60 | 12.68M | 10,490,736 | — | ↗ |
| 2023-05-25 | Prichard Heather Ledbetter | Officer | M-Exempt | A | Common Stock | 64,990 | 1.19 | 77.3K | 74,179 | — | ↗ |
| 2023-05-25 | Niklason Laura E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,625,000 | 2.75 | 7.22M | 15,365,736 | — | ↗ |
| 2023-05-25 | Dougan Brady W | Director / 10% Owner | S-Sale | D | Common Stock | 2,625,000 | 2.75 | 7.22M | 15,365,736 | — | ↗ |
| 2023-05-25 | Ayabudge LLC | 10% Owner | S-Sale | D | Common Stock | 2,625,000 | 2.75 | 7.22M | 15,365,736 | — | ↗ |
| 2023-05-24 | Prichard Heather Ledbetter | Officer | M-Exempt | D | Stock Options (right to buy) | 13,789 | 1.19 | 16.4K | 64,990 | — | ↗ |
| 2023-05-18 | Constantino Michael T. | Director | P-Purchase | A | Common Stock | 4,750 | 4.18 | 19.9K | 9,250 | — | ↗ |
| 2023-03-01 | Niklason Laura E | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 100,000 | 1.19 | 119.0K | 1,270,240 | — | ↗ |
| 2023-03-01 | Dougan Brady W | Director / 10% Owner | M-Exempt | A | Common Stock | 100,000 | 1.19 | 119.0K | 1,270,240 | — | ↗ |
| 2022-12-16 | Sander Dale A. | Officer | P-Purchase | A | Common Stock | 20,000 | 2.60 | 52.0K | 20,600 | — | ↗ |
| 2022-12-16 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 239,538 | 2.53 | 606.0K | 17,990,736 | — | ↗ |
| 2022-12-16 | Dougan Brady W | Director | S-Sale | D | Common Stock | 239,538 | 2.53 | 606.0K | 17,990,736 | — | ↗ |
| 2022-12-16 | Ayabudge LLC | Director | S-Sale | D | Common Stock | 239,538 | 2.53 | 606.0K | 17,990,736 | — | ↗ |
| 2022-12-15 | Niklason Laura E | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 2.54 | 25.4K | 1,170,240 | — | ↗ |
| 2022-12-15 | Dougan Brady W | Director | P-Purchase | A | Common Stock | 10,000 | 2.54 | 25.4K | 1,170,240 | — | ↗ |
| 2022-12-15 | Ayabudge LLC | Director | S-Sale | D | Common Stock | 93,426 | 2.63 | 245.7K | 18,230,274 | — | ↗ |
| 2022-12-14 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 276,304 | 2.76 | 762.6K | 18,323,700 | — | ↗ |
| 2022-12-14 | Dougan Brady W | Director | S-Sale | D | Common Stock | 276,304 | 2.76 | 762.6K | 18,323,700 | — | ↗ |
| 2022-12-14 | Ayabudge LLC | Director | S-Sale | D | Common Stock | 276,304 | 2.76 | 762.6K | 18,323,700 | — | ↗ |
| 2022-12-13 | Scheessele William John | Officer | P-Purchase | A | Common Stock | 5,000 | 3.09 | 15.5K | 15,525 | — | ↗ |
| 2022-12-13 | Sander Dale A. | Officer | W-Will | A | Common Stock | 600 | 0.00 | — | 600 | — | ↗ |
| 2022-12-13 | Niklason Laura E | Director / Officer | S-Sale | D | Common Stock | 330,000 | 2.84 | 937.2K | 18,600,004 | — | ↗ |
| 2022-12-13 | Dougan Brady W | Director | S-Sale | D | Common Stock | 330,000 | 2.84 | 937.2K | 18,600,004 | — | ↗ |
| 2022-12-13 | Ayabudge LLC | Director | S-Sale | D | Common Stock | 330,000 | 2.84 | 937.2K | 18,600,004 | — | ↗ |
| 2022-12-12 | Prichard Heather Ledbetter | Officer | M-Exempt | A | Common Stock | 6,564 | 1.15 | 7.5K | 9,189 | — | ↗ |
| 2022-12-08 | Scheessele William John | Officer | A-Award | A | Stock Options (right to buy) | 136,000 | 0.00 | — | 136,000 | — | ↗ |
| 2022-12-08 | Sander Dale A. | Officer | A-Award | A | Stock Options (right to buy) | 136,000 | 0.00 | — | 136,000 | — | ↗ |
| 2022-12-08 | Prichard Heather Ledbetter | Officer | A-Award | A | Stock Options (right to buy) | 136,000 | 0.00 | — | 136,000 | — | ↗ |
| 2022-12-08 | Parikh Shamik J | Officer | A-Award | A | Stock Options (right to buy) | 91,120 | 0.00 | — | 91,120 | — | ↗ |
| 2022-12-08 | Niklason Laura E | Director / Officer | A-Award | A | Stock Options (right to buy) | 444,500 | 0.00 | — | 444,500 | — | ↗ |
| 2022-12-08 | Dougan Brady W | Director | A-Award | A | Stock Options (right to buy) | 444,500 | 0.00 | — | 444,500 | — | ↗ |
| 2022-09-19 | Cao Yang | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-09-15 | Niklason Laura E | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 4.14 | 8.3K | 1,160,240 | — | ↗ |
| 2022-09-15 | Green Charles Bruce | Director | A-Award | A | Stock Options (right to buy) | 13,000 | 4.09 | 53.2K | 13,000 | — | ↗ |
| 2022-09-15 | Dougan Brady W | Director / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 4.14 | 8.3K | 1,160,240 | — | ↗ |
| 2022-09-15 | Ayabudge LLC | 10% Owner | S-Sale | D | Common Stock | 1,522,500 | 4.00 | 6.09M | 18,930,004 | — | ↗ |
| 2022-09-02 | Binder Gordon M | Director | P-Purchase | A | Common Stock | 61,841 | 4.40 | 272.1K | 110,000 | — | ↗ |
| 2022-09-01 | Binder Gordon M | Director | P-Purchase | A | Common Stock | 48,159 | 4.00 | 192.6K | 48,159 | — | ↗ |
| 2022-06-09 | Windham-Bannister Susan Richards | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 4.34 | 36.9K | 8,500 | — | ↗ |
| 2022-06-09 | Wallace Max N. | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 0.00 | — | 8,500 | — | ↗ |
| 2022-06-09 | Shukla Rajiv | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 4.34 | 36.9K | 8,500 | — | ↗ |
| 2022-06-09 | Seimetz Diane | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-06-09 | Sebelius Kathleen | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 4.34 | 36.9K | 8,500 | — | ↗ |
| 2022-06-09 | Pope Todd | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 0.00 | — | 8,500 | — | ↗ |
| 2022-06-09 | Niklason Laura E | Director / Officer | A-Award | A | Stock Options (right to buy) | 8,500 | 0.00 | — | 8,500 | — | ↗ |
| 2022-06-09 | Dougan Brady W | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 0.00 | — | 8,500 | — | ↗ |
| 2022-06-09 | Constantino Michael T. | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 0.00 | — | 8,500 | — | ↗ |
| 2022-06-09 | Brown Emery N. | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 0.00 | — | 8,500 | — | ↗ |
| 2022-06-09 | Binder Gordon M | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 4.34 | 36.9K | 8,500 | — | ↗ |
| 2022-05-24 | Scheessele William John | Officer | P-Purchase | A | Common Stock | 10,525 | 4.72 | 49.7K | 10,525 | — | ↗ |
| 2022-05-23 | Niklason Laura E | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 4.83 | 48.3K | 1,158,240 | — | ↗ |
| 2022-05-23 | Dougan Brady W | Director | P-Purchase | A | Common Stock | 10,000 | 4.83 | 48.3K | 1,158,240 | — | ↗ |
| 2022-05-23 | Constantino Michael T. | Director | P-Purchase | A | Common Stock | 2,000 | 4.83 | 9.7K | 4,500 | — | ↗ |
| 2022-05-17 | Sander Dale A. | Officer | P-Purchase | A | Common Stock | 2,000 | 4.53 | 9.1K | 2,000 | — | ↗ |
| 2022-04-04 | Parikh Shamik J | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-16 | Niklason Laura E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 75,000 | 9.00 | 675.0K | 510,161 | — | ↗ |
| 2021-12-16 | Dougan Brady W | Director / 10% Owner | S-Sale | D | Common Stock | 75,000 | 9.00 | 675.0K | 510,161 | — | ↗ |
| 2021-12-15 | Niklason Laura E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 125,000 | 8.89 | 1.11M | 585,161 | — | ↗ |
| 2021-12-15 | Dougan Brady W | Director / 10% Owner | S-Sale | D | Common Stock | 125,000 | 8.89 | 1.11M | 585,161 | — | ↗ |
| 2021-12-14 | Niklason Laura E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 76,306 | 9.33 | 711.6K | 710,161 | — | ↗ |
| 2021-12-14 | Dougan Brady W | Director / 10% Owner | S-Sale | D | Common Stock | 23,694 | 9.80 | 232.2K | 786,467 | — | ↗ |
| 2021-11-22 | Constantino Michael T. | Director | P-Purchase | A | Common Stock | 2,300 | 10.79 | 24.8K | 2,500 | — | ↗ |
| 2021-10-13 | Windham-Bannister Susan Richards | Director | A-Award | A | Stock Options (right to buy) | 13,000 | 10.03 | 130.4K | 13,000 | — | ↗ |
| 2021-10-13 | Wallace Max N. | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 10.03 | 85.3K | 8,500 | — | ↗ |
| 2021-10-13 | Shukla Rajiv | Director | A-Award | A | Stock Options (right to buy) | 13,000 | 10.03 | 130.4K | 13,000 | — | ↗ |
| 2021-10-13 | Sebelius Kathleen | Director | A-Award | A | Stock Options (right to buy) | 8,500 | 10.03 | 85.3K | 8,500 | — | ↗ |
| 2021-10-13 | Scheessele William John | Officer | A-Award | A | Stock Options (right to buy) | 157,558 | 10.03 | 1.58M | 157,558 | — | ↗ |
| 2021-10-13 | Pope Todd | Director | A-Award | A | Stock Options (right to buy) | 13,000 | 10.03 | 130.4K | 13,000 | — | ↗ |
| 2021-10-13 | Niklason Laura E | Director / Officer / 10% Owner | A-Award | A | Stock Options (right to buy) | 8,500 | 10.03 | 85.3K | 8,500 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-4.9K
Shares Outstanding
156.77M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Laura E. Niklason President and Chief Executive Officer | 633.6K | 254.0K | — | 4.33M | — | 14.6K | 5.23M | 82.77% | ↗ |
| 2 | 2025 | Dale A. Sander Chief Financial Officer, Chief Corporate Development Officer and Treasurer | 546.0K | 175.0K | 382.7K | 1.01M | — | 14.6K | 2.13M | 65.50% | ↗ |
| 3 | 2025 | Shamik J. Parikh Chief Medical Officer | 519.5K | 166.3K | 382.7K | 1.01M | — | 14.6K | 2.10M | 66.59% | ↗ |
| 4 | 2024 | Laura E. Niklason President and Chief Executive Officer | 612.4K | 278.6K | — | — | — | 14.4K | 905.4K | 0.00% | ↗ |
| 5 | 2024 | Dale A. Sander Chief Financial Officer, Chief Corporate Development Officer and Treasurer | 505.8K | 184.1K | — | — | — | 14.3K | 704.2K | 0.00% | ↗ |
| 6 | 2024 | Heather Prichard Chief Operating Officer | 468.4K | 170.5K | — | — | — | 14.3K | 653.2K | 0.00% | ↗ |
| 7 | 2023 | Laura E. Niklason President and Chief Executive Officer | 603.8K | 281.7K | — | 1.73M | — | 13.8K | 2.63M | 65.75% | ↗ |
| 8 | 2023 | Dale A. Sander Chief Financial Officer, Chief Corporate Development Officer and Treasurer | 504.5K | 186.1K | — | 647.2K | — | 13.7K | 1.35M | 47.88% | ↗ |
| 9 | 2023 | Heather Prichard Chief Operating Officer | 461.7K | 172.4K | — | 623.5K | — | 13.7K | 1.27M | 49.04% | ↗ |
| 10 | 2022 | Laura E. Niklason President and Chief Executive Officer | 500.0K | 212.5K | — | 1.03M | — | 5.3K | 1.75M | 58.96% | ↗ |
| 11 | 2022 | Shamik J. Parikh Chief Medical Officer | 314.2K | 161.3K | — | 1.02M | — | 39.2K | 1.53M | 66.36% | ↗ |
| 12 | 2022 | Dale A. Sander Chief Financial Officer, Chief Corporate Development Officer and Treasurer | 488.4K | 166.3K | — | 315.5K | — | 12.7K | 983.0K | 32.10% | ↗ |
| 13 | 2021 | Laura E. Niklason President and Chief Executive Officer | 500.0K | 237.5K | — | 10.02M | — | 44.2K | 10.80M | 92.76% | ↗ |
| 14 | 2021 | Jeffrey H. Lawson Former Chief Surgical Officer | 583.5K | 309.3K | — | — | — | 14.3K | 907.0K | 0.00% | ↗ |
| 15 | 2021 | Heather Prichard Chief Operating Officer | 369.6K | 194.9K | — | — | — | 12.0K | 576.4K | 0.00% | ↗ |
| 16 | 2021 | Rajiv Shukla Former Chief Executive Officer of AHAC | — | — | — | 98.2K | — | 17.3K | 115.4K | 85.05% | ↗ |
| 17 | 2020 | Jeffrey H. Lawson Former Chief Surgical Officer | 604.8K | 75.0K | — | 20.0K | — | 14.1K | 713.9K | 2.80% | ↗ |
| 18 | 2020 | Heather Prichard Chief Operating Officer | 371.9K | 80.0K | — | 20.0K | — | 11.8K | 483.7K | 4.14% | ↗ |
| 19 | 2020 | Laura E. Niklason President and Chief Executive Officer | 75.0K | — | — | 20.0K | — | 106.3K | 201.3K | 9.94% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Laura E. Niklason | Founder, President, Chief Executive Officer & Director | 902.2K | — |
| Dale A. Sander | Chief Financial Officer, Chief Corporate Development Officer & Treasurer | 735.5K | male |
| Shamik J. Parikh | Chief Medical Officer | 700.4K | — |
| Jim Mercadante | Chief Commercial Officer | — | male |
| Lisa Molyneux | Executive Vice President of Enterprise Planning & Analysis | — | female |
| Rick McElheny | Senior Vice President of Business Development | — | male |
| Sabrina Osborne | Chief People Officer | — | female |
| Heather Connelly | Executive Vice President Regulatory Affairs & Quality | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2024-05-03 | 2024-06-14 | Tommy Tuberville | AL | Joint | Sale (Partial) | $15,001 - $50,000 | ↗ |
| 2024-05-03 | 2024-06-14 | Tommy Tuberville | AL | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2024-04-30 | 2024-05-15 | Tommy Tuberville | AL | Joint | Sale (Partial) | $50,001 - $100,000 | ↗ |
| 2024-03-21 | 2024-04-15 | Tommy Tuberville | AL | Joint | Purchase | $15,001 - $50,000 | ↗ |
| 2024-02-12 | 2024-03-15 | Tommy Tuberville | AL | Joint | Purchase | $15,001 - $50,000 | ↗ |
| 2024-01-19 | 2024-02-14 | Tommy Tuberville | AL | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2023-07-25 | 2023-08-14 | Tommy Tuberville | AL | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2022-03-30 | 2022-04-08 | Tommy Tuberville | AL | Joint | Purchase | $15,001 - $50,000 | ↗ |
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HUMA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
